Ekso Bionics (EKSO) Stock Analysis

What Ekso Bionics does

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

Key metrics

ETFs linked to EKSO

Broad-market and Technology sector ETFs an investor holding Ekso Bionics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how EKSO fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Ekso Bionics?

Ekso Bionics trades under the ticker EKSO on NASDAQ.

Which exchange is EKSO listed on?

EKSO is listed on NASDAQ.

What sector does Ekso Bionics operate in?

Ekso Bionics is classified in the Technology sector (Information Technology Services industry).

How can PortView help analyze EKSO in a portfolio?

PortView shows EKSO's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.